Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10562896 6-5 fused rings as C5a inhibitors

Patent 10562896 was granted and assigned to ChemoCentryx on February, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

ChemoCentryx

Current Assignee

ChemoCentryx

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

105628960

Patent Inventor Names

Yibin Zeng0

Christopher W. Lange0

Hiroko Tanaka0

Penglie Zhang0

Pingchen Fan0

Rajinder Singh0

Rebecca M. Lui0

Sreenivas Punna0

...

Date of Patent

February 18, 2020

Patent Application Number

159917030

Date Filed

May 29, 2018

Patent Citations

‌

US Patent 10035768 C5aR antagonists

Patent Citations Received

‌

US Patent 11384079 6-5 fused rings as C5a inhibitors

‌

US Patent 11479553 5-5 fused rings as C5a inhibitors

‌

US Patent 11485737 Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors

‌

US Patent 11608336 Prodrugs of fused-bicyclic C5aR antagonists

‌

US Patent 11773091 6-5 fused rings as C5a inhibitors

‌

US Patent 11478460 Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors

Patent Primary Examiner

‌

D Margaret M Seaman

Patent abstract

The present disclosure provides, inter alia, Compounds of Formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10562896 6-5 fused rings as C5a inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API